Back to search
Moderate Clostridium Difficile Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate Clostridium Difficile Infection trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Moderate Clostridium Difficile Infection trials you may qualify forClostridium difficile infection (CDI) is a leading cause of hospital-associated gastrointestinal illness, associated with significant morbidity and mortality an…
Patients diagnosed to have mild-moderate CDI will be randomized to receive IM-01 egg-derived anti-C. difficile polyclonal antibodies in increasing dosages, twic…
This study will assess the safety and efficacy of multiple daily dosing of oral LFF571 in patients who have moderate Clostridium difficile infections.